For most independents, an evidence-based, value-driven formulary is a necessary component of a successful customer retention and new business development strategy. I applaud McKesson’s development of PATH Pro.
—Mark Prifogle, HFA, LNHA, FACHCA Chief Executive Officer and Group President | GrandView Health Services